Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 47

1.

Clinical use of bone turnover markers to monitor pharmacologic fracture prevention therapy.

Schousboe JT, Bauer DC.

Curr Osteoporos Rep. 2012 Mar;10(1):56-63. doi: 10.1007/s11914-011-0091-y. Review.

2.

Denosumab, a new pharmacotherapy option for postmenopausal osteoporosis.

Josse R, Khan A, Ngui D, Shapiro M.

Curr Med Res Opin. 2013 Mar;29(3):205-16. doi: 10.1185/03007995.2013.763779. Epub 2013 Jan 25. Review. Erratum in: Curr Med Res Opin. 2013 Sep;29(9):1211.

PMID:
23297819
3.
4.
5.

Three years of treatment with minodronate in patients with postmenopausal osteoporosis.

Hagino H, Shiraki M, Fukunaga M, Nakano T, Takaoka K, Ohashi Y, Nakamura T, Matsumoto T.

J Bone Miner Metab. 2012 Jul;30(4):439-46. doi: 10.1007/s00774-011-0332-2. Epub 2011 Dec 2.

6.

Going on a drug holiday?

Bonnick SL.

J Clin Densitom. 2011 Oct-Dec;14(4):377-83. doi: 10.1016/j.jocd.2011.07.006. No abstract available.

PMID:
22051091
7.

Comparative effectiveness of osteoporosis drugs in preventing secondary nonvertebral fractures in Taiwanese women.

Lin TC, Yang CY, Yang YH, Lin SJ.

J Clin Endocrinol Metab. 2013 Dec;98(12):4717-26. doi: 10.1210/jc.2013-1877. Epub 2013 Sep 30.

PMID:
24081731
8.

Postmenopausal osteoporosis: fracture risk and prevention.

Kaunitz AM, McClung MR, Feldman RG, Wysocki S.

J Fam Pract. 2009 Nov;58(11 Suppl Postmenopausal):S1-6.

PMID:
19891943
9.

Validity of bone marker measurements for monitoring response to bisphosphonate therapy with zoledronic acid in metastatic breast cancer.

Aktas B, Kasimir-Bauer S, Lehmann N, Kimmig R, Tewes M.

Oncol Rep. 2013 Jul;30(1):441-7. doi: 10.3892/or.2013.2409. Epub 2013 Apr 22.

PMID:
23604361
10.

Low incidence of anti-osteoporosis treatment after hip fracture.

Rabenda V, Vanoverloop J, Fabri V, Mertens R, Sumkay F, Vannecke C, Deswaef A, Verpooten GA, Reginster JY.

J Bone Joint Surg Am. 2008 Oct;90(10):2142-8. doi: 10.2106/JBJS.G.00864.

11.

Zoledronic acid increases bone density but does not reduce fractures in frail elderly people, study finds.

Kmietowicz Z.

BMJ. 2015 Apr 13;350:h1949. doi: 10.1136/bmj.h1949. No abstract available.

PMID:
25872930
12.

Overlapping and continued alendronate or raloxifene administration in patients on teriparatide: effects on areal and volumetric bone mineral density--the CONFORS Study.

Muschitz C, Kocijan R, Fahrleitner-Pammer A, Pavo I, Haschka J, Schima W, Kapiotis S, Resch H.

J Bone Miner Res. 2014 Aug;29(8):1777-85. doi: 10.1002/jbmr.2216.

13.

[New development in bisphosphonate treatment. Review of effect on bone metabolism by minodronic acid in primary osteoporosis].

Fukunaga M.

Clin Calcium. 2009 Jan;19(1):63-73. doi: CliCa09016373. Review. Japanese.

PMID:
19122266
14.

Effects of pharmaceutical care on adherence and persistence to bisphosphonates in postmenopausal osteoporotic women.

Lai PS, Chua SS, Chew YY, Chan SP.

J Clin Pharm Ther. 2011 Oct;36(5):557-67. doi: 10.1111/j.1365-2710.2010.01210.x. Epub 2010 Oct 26.

PMID:
21916908
15.

Controversies in osteoporosis management: antiresorptive therapy for preventing bone loss: when to use one or two antiresorptive agents?

Gallagher JC, Tella SH.

Clin Obstet Gynecol. 2013 Dec;56(4):749-56. doi: 10.1097/GRF.0b013e3182a982c2. Review.

16.

Maximizing effectiveness of bisphosphonate therapy for osteoporosis.

Martens MG, Shaw H.

South Med J. 2008 Aug;101(8):824-30. doi: 10.1097/SMJ.0b013e31817fd436.

PMID:
18622322
17.

Real-world challenges of treating osteoporosis.

Owens G.

Am J Manag Care. 2011 May;17 Suppl 6:S177-84. Review.

PMID:
21882487
18.

Vertebral anti-fracture efficacy of strontium ranelate according to pre-treatment bone turnover.

Collette J, Bruyère O, Kaufman JM, Lorenc R, Felsenberg D, Spector TD, Diaz-Curiel M, Boonen S, Reginster JY.

Osteoporos Int. 2010 Feb;21(2):233-41. doi: 10.1007/s00198-009-0940-z. Epub 2009 May 13.

19.

Bridging the osteoporosis treatment gap: performance and cost-effectiveness of a fracture liaison service.

Yates CJ, Chauchard MA, Liew D, Bucknill A, Wark JD.

J Clin Densitom. 2015 Apr-Jun;18(2):150-6. doi: 10.1016/j.jocd.2015.01.003. Epub 2015 Mar 18.

PMID:
25797867
20.

Anti-osteoporosis therapy and fracture healing.

Larsson S, Fazzalari NL.

Arch Orthop Trauma Surg. 2014 Feb;134(2):291-7. doi: 10.1007/s00402-012-1558-8. Epub 2012 Jun 9. Review.

PMID:
22684739

Supplemental Content

Support Center